By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Grunenthal GmbH 

Pascalstraße 6

Aachen    52076  Germany
Phone: 0241-569-1111 Fax: 0241-569-1112


SEARCH JOBS


Industry
Pharmaceutical






Company News
Grunenthal Appoints Gabriel Baertschi As Chairman Of The Corporate Executive Board And Chief Executive Officer Effective October 1, 2016 6/7/2016 10:41:51 AM
AstraZeneca PLC (AZN) Unloads Gout Drug Rights to Grunenthal in $230 Million+ Deal 6/2/2016 6:02:12 AM
Grunenthal Announces Exclusive License Agreement For Commercialization Of Innovative Surgical Glue In The EU And Latin America 5/12/2016 6:38:54 AM
Grunenthal To Acquire Almirall de Mexico, S.A. de C.V. 3/16/2016 7:02:14 AM
Patheon (PTI.TO) Selected By Grunenthal To Develop Drugs Using INTAC® Abuse Deterrent Formulations Technology 2/22/2016 12:24:47 PM
Grunenthal GmbH's Innovative Medicines Unit (IMU) Opens Its First Innovation Hub To Further Strengthen The Company's Networked Research And Development Approach 1/6/2016 9:11:11 AM
Depomed (DEPO) Acquires U.S. Rights To Late-Stage, First-In-Class Pain Product From Grunenthal GmbH 11/18/2015 6:32:37 AM
AYOXXA And Grunenthal GmbH Completed Research Collaboration 6/24/2015 9:16:37 AM
BIO2015 EXCLUSIVE: Public/Private Partnerships “Key Way to Bring Innovation,” Says Grunenthal GmbH CSO 6/22/2015 2:41:50 PM
Grunenthal GmbH Boston Children's Hospital and Proteus, S.A. Forge $85 Million+ Neosaxitoxin Pact 6/15/2015 6:50:29 AM
12345
//-->